StocksFin Logo
ABCM logo
$ABCM

Abcam plc

ABCM country of incorporation
|
|
Mr. Alan Thomas Hirzel BS, MS, MBA
|
1,682 employees
NASDAQ | Healthcare | Biotechnology
ABCM reported its Q321 earnings on September 30, 2020 (194 weeks ago).
$65M 80.5% vs. Q316 Revenues Q321
69.31% -1.7% vs. Q316 Gross Profit Margin
4.81% -81.5% vs. Q316 Net Profit Margin
14.7M -46.2% vs. Q316 Free Cash Flow Q321
$0.02 -67.7% vs. Q316 EPS Q321
Company Card Q321
As reported on September 30, 2020
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q321
As reported on September 30, 2020
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2021
297.7M
85.9M
297.7M
$0.08
Q32021
65M
19.95M
3.13M
$0.02
FY2020
260M
79.8M
12.5M
$0.06
Q42020
65M
+0%
19.95M
3.13M
0%
$0.02
Q22020
65M
+0%
19.95M
3.13M
0%
$0.02
Q12020
65M
+0%
19.95M
3.13M
0%
$0.02
FY2019
259.9M
76.7M
45M
$0.22
FY2018
233.2M
70.2M
62.2M
$0.31
FY2017
217.1M
65M
42.36M
$0.21
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q22022
1.06B
337.1M
109.6M
229.9M
727.6M
FY2021 No data.
FY2020
811.4M
308.8M
187.3M
347.9M
502.6M
FY2019
446.7M
61.9M
87.1M
0
384.8M
FY2018
414.8M
63.1M
90.2M
0
351.7M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY 2021
71.9M
-45.8M
8.9M
-57.2M
14.7M
Q32021
15.75M
0
0
-8.93M
6.83M
FY2020
63M
-148.1M
184.6M
-35.7M
27.3M
FY2019
70.2M
-49.9M
-24.7M
-40.4M
29.8M
FY2018
63.3M
-37.7M
-20.6M
-37.4M
25.9M
FY2017
66.38M
-33.02M
-17.73M
-19.17M
47.21M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees